BCTXL · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2026-06-09 compared with 2026-03-10 · 3 added, 2 removed, 22 unchanged (19% of the section changed)
Other Information.
+Added: During the three months ended April
+Added: 30 2026, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement”
+Added: or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
15 unchanged sentences
THERAPEUTICS CORP.
−Removed: March 10, 2026
Executive Officer
Executive Officer)
−Removed: March 10, 2026
Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.